Across TCGA pan-cancer cohorts, NUDT19P6 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of NUDT19P6’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where NUDT19P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NUDT19P6 is over-expressed in tumor.

HNSC are the cancer types where NUDT19P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NUDT19P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.027	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

NUDT19P6–HNSC

Tumor-vs-normal expression box plot for NUDT19P6 RNA in HNSC.

Open the HNSC breakdown →

Exploration

Same gene, other analysis: NUDT19P6 RNA expression & survival · all NUDT19P6 data types